SHPAX vs. PRHSX
SHPAX (Saratoga Health & Biotechnology Fund) and PRHSX (T. Rowe Price Health Sciences Fund) are both Health & Biotech Equities funds. Over the past 10 years, SHPAX returned 6.90%/yr vs 11.23%/yr for PRHSX. Their correlation of 0.84 means they have usually moved in the same direction. SHPAX charges 2.90%/yr vs 0.83%/yr for PRHSX.
Performance
SHPAX vs. PRHSX - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with SHPAX having a 8.70% return and PRHSX slightly lower at 8.63%. Over the past 10 years, SHPAX has underperformed PRHSX with an annualized return of 6.90%, while PRHSX has yielded a comparatively higher 11.23% annualized return.
SHPAX
- 1D
- -0.43%
- 1M
- 0.61%
- 6M
- 6.99%
- YTD
- 8.70%
- 1Y
- 28.95%
- 3Y*
- 9.65%
- 5Y*
- 5.82%
- 10Y*
- 6.90%
- ALL TIME*
- 6.58%
PRHSX
- 1D
- -0.35%
- 1M
- -1.27%
- 6M
- 9.71%
- YTD
- 8.63%
- 1Y
- 33.31%
- 3Y*
- 9.96%
- 5Y*
- 3.65%
- 10Y*
- 11.23%
- ALL TIME*
- 13.18%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $0.00 | $0.00 | $0.00 | |
| $0.00 | $0.00 | $0.00 |
SHPAX vs. PRHSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 8.70% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
PRHSX T. Rowe Price Health Sciences Fund | 8.63% | 17.75% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
Correlation
The correlation between SHPAX and PRHSX is 0.80, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.80 |
Correlation (3Y) Balances recent behavior with more history. | 0.78 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.82 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.81 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2000 | 0.84 |
The correlation between SHPAX and PRHSX has been stable across timeframes, ranging from 0.78 to 0.84 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SHPAX vs. PRHSX — Risk / Return Rank
SHPAX
PRHSX
SHPAX vs. PRHSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Health & Biotechnology Fund (SHPAX) and T. Rowe Price Health Sciences Fund (PRHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SHPAX | PRHSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.18 | ||
| Sortino ratioReturn per unit of downside risk | -0.27 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.33 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 2.85 | 2.50 | +0.35 |
| Martin ratioReturn relative to average drawdown | 7.30 | 6.96 | +0.34 |
Loading charts...
Drawdowns
SHPAX vs. PRHSX - Drawdown Comparison
The maximum SHPAX drawdown since its inception was -69.50%, which is greater than PRHSX's maximum drawdown of -42.96%. Use the drawdown chart below to compare losses from any high point for SHPAX and PRHSX.
Loading charts...
Drawdown Indicators
| SHPAX | PRHSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.50% | -42.96% | -26.54% |
Max Drawdown (1Y)Largest decline over 1 year | -9.33% | -12.81% | +3.48% |
Max Drawdown (3Y)Largest decline over 3 years | -16.32% | -21.00% | +4.68% |
Max Drawdown (5Y)Largest decline over 5 years | -16.32% | -27.61% | +11.29% |
Max Drawdown (10Y)Largest decline over 10 years | -28.05% | -28.97% | +0.92% |
Current DrawdownCurrent decline from peak | -1.20% | -2.23% | +1.03% |
Average DrawdownAverage peak-to-trough decline | -27.78% | -8.71% | -19.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.65% | 4.59% | -0.94% |
Volatility
SHPAX vs. PRHSX - Volatility Comparison
Saratoga Health & Biotechnology Fund (SHPAX) has a higher volatility of 5.55% compared to T. Rowe Price Health Sciences Fund (PRHSX) at 5.14%. This indicates that SHPAX's price experiences larger fluctuations and is considered to be riskier than PRHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SHPAX | PRHSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.55% | 5.14% | +0.41% |
Volatility (6M)Calculated over the trailing 6-month period | 11.34% | 12.96% | -1.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.93% | 16.35% | -1.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.53% | 17.46% | -2.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.65% | 19.27% | -2.62% |
SHPAX vs. PRHSX - Expense Ratio Comparison
SHPAX has a 2.90% expense ratio, which is higher than PRHSX's 0.83% expense ratio.
Dividends
SHPAX vs. PRHSX - Dividend Comparison
SHPAX's dividend yield for the trailing twelve months is around 3.37%, less than PRHSX's 11.13% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 11.13% | 12.09% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
SHPAX Saratoga Health & Biotechnology Fund | 3.37% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
Frequently Asked Questions
SHPAX and PRHSX have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SHPAX has higher volatility (5.55%) compared to PRHSX (5.14%). In terms of maximum drawdown, SHPAX dropped -69.50% vs PRHSX's -42.96%.
PRHSX currently has the higher Sharpe Ratio (1.96 vs 1.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SHPAX and PRHSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer